NeuroMetrix Celebrates 20 Year Anniversary

WALTHAM, Mass.--()--NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it is celebrating its twenty year anniversary.

NeuroMetrix was incorporated in Cambridge, Massachusetts on June 6, 1996 as a spin-off from the Harvard-MIT Division of Health Sciences and Technology. The Company moved its headquarters to Waltham, Massachusetts in 2001 where it is currently located. Initial funding for NeuroMetrix was provided by several venture capital firms. The Company executed an initial public offering of its common stock and was listed on Nasdaq in 2004. Throughout its twenty year history, Company products have always been proudly manufactured in the USA.

The Company’s core technology involves sophisticated hardware and software algorithms in the areas of neuro-stimulation and neuro-measurement. Its first commercial product was the NC-stat® device launched in 1999. The original NC-stat was a rapid, accurate and cost-effective test for Carpal Tunnel Syndrome. About three million patients have benefited from diagnostic testing with the NC-stat line of products, including the current NC-stat DPNCheck® device. The Company’s most recent product is Quell®, an over-the-counter wearable device for treating chronic pain, which was launched in June 2015. In its first year on the market, over 20,000 chronic pain sufferers have tried Quell, with most reporting substantial pain relief.

"It is an honor to have had the opportunity to help so many patients over these past twenty years though our novel and advanced products,” said Shai N. Gozani, M.D., Ph.D., Founder, President and CEO of NeuroMetrix. "I want to thank our past and present employees for their commitment to our mission, the many physicians who used and endorsed our products, and our investors for their patience and vision. Together we have accomplished a great deal in the past twenty years. Most importantly, the future is very bright as we continue to innovate and focus on the needs of patients.”

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

$Cashtags

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com